Mode
Text Size
Log in / Sign up
N/A N=169 Randomized Single-blind Treatment

CPAP (Continuous Positive Airway Pressure) Study Educational Materials and Usage Feedback to Promote CPAP Adherence

Adherence

Enrolled (actual)
169
Serious AEs
0.0%
Results posted
Apr 2019
Primary outcome: Primary: Nightly Adherence — 4.83; 5.82; 4.82; 4.60 hours

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Education and feedback (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Philips Respironics
Primary completion
May 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Nightly Adherence
4.83; 5.82; 4.82; 4.60; 4.96; 4.19
PRIMARY
Adherence
5.5; 5.8; 4.9
SECONDARY
Participant's Feedback on Educational Pamphlets - Expectations Scale
4.42; 4.39; 4.33; 4.10; 4.01; 4.07
SECONDARY
Participant's Feedback on Educational Pamphlets - Importance Scale
4.69; 4.58; 4.65; 4.53; 4.63; 4.62
SECONDARY
Participant's Feedback on Educational Pamphlets - Self-Efficacy Scale
4.49; 4.20; 4.29; 4.26; 4.14; 4.07
SECONDARY
Participant's Feedback on Educational Pamphlets - Motiviation
9.59; 9.32; 9.21; 9.10; 8.82; 8.85
SECONDARY
Participant's Feedback on Educational Pamphlets - Leaflet Assessment
4.12; 4.04; 3.94; 3.95; 4.07; 3.99

Summary

The study hypothesis: in groups receiving tailored education and feedback in a style that matches their psychological profile, will show a higher CPAP adherence rates than groups receiving mismatched tailored education / feedback, and groups that receive no tailored education and feedback (standard of care).

Eligibility Criteria

Inclusion Criteria

  • Males or females, ages 21-80 years
  • Prescribed to start CPAP treatment and diagnosed with mild to severe OSA.
  • Recently (within study period) diagnosed with Mild to Severe OSA defined as an Apnea-Hypopnea Index of equal to or greater than 10 events per hour of sleep.
  • CPAP treatment naïve

Exclusion Criteria

  • Inability to provide informed consent
  • Presence of a comorbid condition that may potentially complicate CPAP adherence, such as:
  • Unstable depressive disorder
  • Unstable anxiety disorder
  • Dementia
  • Unable to understand study information
  • Obesity Hypoventilation Syndrome
  • Central Sleep Apnea or Complex Sleep Apnea
  • Facial musculoskeletal disorder
  • Unwillingness or inability to use CPAP therapy
  • Unable to return for follow up appointment
  • Use of supplemental oxygen
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02195531). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search